Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Hubert Pakula, PhD
/
Co-authored with Filippo Pederzoli
Co-authored publications
Hubert Pakula, PhD and Filippo Pederzoli · 11 publications
CSV
Word
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applications.
NPJ precision oncology
· 2026
HP
Hubert Pakula
FP
Filippo Pederzoli
GN
Giuseppe Nicolo Fanelli
MS
Mara Serena Serafini
+3 more →
PV
Pier Vitale Nuzzo
PMID:
42185453
·
PMCID:
PMC13478609
·
DOI
·
Abstract
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.
bioRxiv : the preprint server for biology
· 2026
HP
Hubert Pakula
FP
Filippo Pederzoli
SD
Silvia Daniele Rodrigues
PV
Pier Vitale Nuzzo
+2 more →
ML
Massimo Loda
PMID:
41928980
·
PMCID:
PMC13041901
·
DOI
·
Abstract
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs).
Gene
· 2026
HP
Hubert Pakula
FP
Filippo Pederzoli
SD
Silvia Daniele Rodrigues
RG
Richard Garner
+4 more →
ML
Massimo Loda
PMID:
41905611
·
PMCID:
PMC13070296
·
DOI
·
Abstract
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
Prostate cancer and prostatic diseases
· 2026
HP
Hubert Pakula
FP
Filippo Pederzoli
SB
Sara Bleve
SD
Silvia Daniele Rodrigues
+3 more →
ML
Massimo Loda
PMID:
41820670
·
PMCID:
PMC13139911
·
DOI
·
1 citations
·
Abstract
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors.
Critical reviews in oncology/hematology
· 2025
HP
Hubert Pakula
FP
Filippo Pederzoli
PV
Pier Vitale Nuzzo
SD
Silvia Daniele Rodrigues
+5 more →
ML
Massimo Loda
PMID:
40846043
·
DOI
·
27 citations
·
Abstract
Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza)
Journal of Clinical Oncology
· 2024
Source: Scopus
·
DOI
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component.
Cancers
· 2024
HP
Hubert Pakula
FP
Filippo Pederzoli
GN
Giuseppe Nicolò Fanelli
PV
Pier Vitale Nuzzo
+1 more →
ML
Massimo Loda
PMID:
39518123
·
PMCID:
PMC11544791
·
DOI
·
18 citations
·
Abstract
Distinct mesenchymal cell states mediate prostate cancer progression.
Nature communications
· 2024
HP
Hubert Pakula
FP
Filippo Pederzoli
MO
Mohamed Omar
GN
Giuseppe Nicolò Fanelli
+13 more →
ML
Massimo Loda
PMID:
38191471
·
PMCID:
PMC10774315
·
DOI
·
31 citations
·
Abstract
Distinct mesenchymal cell states mediate prostate cancer progression.
bioRxiv : the preprint server for biology
· 2023
HP
Hubert Pakula
FP
Filippo Pederzoli
MO
Mohamed Omar
GN
Giuseppe Nicolò Fanelli
+11 more →
ML
Massimo Loda
PMID:
37034687
·
PMCID:
PMC10081210
·
DOI
·
Abstract
"Stromal cells in prostate cancer pathobiology: friends or foes?".
British journal of cancer
· 2022
HP
Hubert Pakula
FP
Filippo Pederzoli
PV
Pier Vitale Nuzzo
ML
Massimo Loda
PMID:
36482187
·
PMCID:
PMC10006214
·
DOI
·
48 citations
·
Abstract
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine.
Cancers
· 2022
HP
Hubert Pakula
FP
Filippo Pederzoli
GN
Giuseppe Nicolò Fanelli
ML
Massimo Loda
PV
Pier Vitale Nuzzo
PMID:
36139519
·
PMCID:
PMC9497114
·
DOI
·
22 citations
·
Abstract